NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,236 | -99.4% | 301 | -99.4% | 0.00% | -100.0% |
| Q1 2023 | $367,616 | -92.7% | 53,047 | -89.2% | 0.00% | -93.1% |
| Q4 2022 | $5,044,910 | +1317.1% | 490,750 | +2407.4% | 0.03% | +1350.0% |
| Q3 2022 | $356,000 | -73.9% | 19,572 | -26.2% | 0.00% | -75.0% |
| Q2 2022 | $1,364,000 | -65.5% | 26,512 | -50.6% | 0.01% | -75.8% |
| Q1 2022 | $3,955,000 | +11.2% | 53,698 | +116.0% | 0.03% | -2.9% |
| Q4 2021 | $3,557,000 | +546.7% | 24,862 | +836.8% | 0.03% | +385.7% |
| Q3 2021 | $550,000 | -80.5% | 2,654 | -80.0% | 0.01% | -78.1% |
| Q2 2021 | $2,814,000 | +218.3% | 13,254 | +171.9% | 0.03% | +190.9% |
| Q1 2021 | $884,000 | +34.3% | 4,875 | -17.4% | 0.01% | +22.2% |
| Q4 2020 | $658,000 | -31.0% | 5,900 | -32.9% | 0.01% | -35.7% |
| Q3 2020 | $953,000 | +287.4% | 8,793 | +198.5% | 0.01% | +250.0% |
| Q2 2020 | $246,000 | – | 2,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |